# Enveric Biosciences, Inc. > Enveric Biosciences is a biotechnology company **Wikidata**: [Q108426195](https://www.wikidata.org/wiki/Q108426195) **Source**: https://4ort.xyz/entity/enveric-biosciences-inc ## Summary Enveric Biosciences, Inc. is a biotechnology company that is publicly traded on the Nasdaq stock exchange under the ticker symbol ENVM. As a public company, it offers its securities for sale to the general public, allowing investors to purchase shares in the company. The company operates within the biotechnology sector, focusing on developing novel therapeutic candidates. ## Key Facts - **Legal Name**: Enveric Biosciences, Inc. - **Stock Ticker**: ENVM - **Stock Exchange**: Nasdaq - **Industry**: Biotechnology - **Company Type**: Public company (offers securities to the general public) - **Google Knowledge Graph ID**: /g/11dx9fyrqj - **Instance Of**: Company, Public company - **Classification**: A publicly traded biotechnology company ## FAQs **What does Enveric Biosciences, Inc. do?** Enveric Biosciences is a biotechnology company engaged in the development of novel therapeutic candidates, typically focusing on pharmaceutical or medical research initiatives within the biotech sector. **Where is Enveric Biosciences, Inc. traded?** Enveric Biosciences trades on the Nasdaq stock exchange under the ticker symbol ENVM, meaning it is a publicly traded company whose shares can be bought and sold on the open market. **What type of company is Enveric Biosciences?** Enveric Biosciences is classified as a public company—a corporation that offers its securities, such as stock, for sale to the general public through a stock exchange. This distinguishes it from private companies that do not trade shares on public markets. **How can I invest in Enveric Biosciences?** As a Nasdaq-listed public company with ticker ENVM, Enveric Biosciences shares can be purchased through any brokerage account that provides access to Nasdaq-traded securities. ## Why It Matters Enveric Biosciences represents the intersection of biotechnology innovation and public market capital formation. As a publicly traded biotech company, it provides investors with direct opportunities to participate in the potential growth and development of novel therapeutic technologies. The biotechnology sector plays a critical role in advancing medical treatments, pharmaceutical innovations, and healthcare solutions. Publicly traded biotech companies like Enveric Biosciences access capital markets to fund research and development initiatives that can lead to breakthrough treatments for various medical conditions. The company's public status also subjects it to regulatory disclosure requirements, promoting transparency for shareholders and the general public regarding its operations, financial performance, and strategic direction. ## Notable For - Trading on the Nasdaq stock exchange under ticker ENVM - Operating as a publicly held company with shares available for public trading - Being classified within the biotechnology industry sector - Representing the public company structure within the biotech/pharmaceutical space ## Body ### Company Overview Enveric Biosciences, Inc. is a biotechnology company focused on developing innovative therapeutic candidates. The company operates within the biotechnology sector, which encompasses companies that apply biological science to develop products and technologies for medical, pharmaceutical, and agricultural applications. As a biotech company, Enveric Biosciences is likely engaged in research and development activities related to drug discovery, clinical trials, and the advancement of novel treatments for various diseases and medical conditions. ### Public Company Status Enveric Biosciences qualifies as a public company under the definition of a corporation that offers its securities for sale to the general public. This classification carries significant implications for the company's structure and operations: - **Capital Formation**: As a public company, Enveric Biosciences can raise capital by issuing shares to the general public through its listing on Nasdaq. This provides access to a broader pool of investors compared to private company funding sources. - **Ownership Structure**: The company's ownership is distributed among public shareholders who hold shares purchased through the stock exchange. This contrasts with private companies where ownership is typically held by a smaller group of investors, founders, or venture capital firms. - **Regulatory Requirements**: As a publicly traded company, Enveric Biosciences is subject to disclosure and reporting requirements that promote transparency. These requirements typically include periodic financial reporting, disclosure of material events, and other regulatory obligations designed to protect investors. - **Liquidity**: The public trading of its shares provides liquidity for investors, allowing them to buy and sell ownership stakes relatively easily through the stock market. ### Stock Exchange Listing Enveric Biosciences is listed on the Nasdaq stock exchange, one of the major U.S. stock exchanges known for listing technology and biotechnology companies. The company's ticker symbol is ENVM, which is used to identify the company's stock in trading systems and market data. The Nasdaq listing provides the company with visibility within the investment community and access to the substantial trading volume that occurs on this exchange. The presence of a stock exchange listing (Nasdaq) with a specific ticker (ENVM) is a key identifier for the company in financial markets and financial data systems. ### Classification and Relationships Enveric Biosciences holds the following classifications based on the provided source material: - **Instance Of**: Company, Public company - **Industry Classification**: Biotechnology - **Geographic Market**: U.S. public markets (through Nasdaq) The company exists within the broader ecosystem of publicly traded biotechnology firms, a sector known for high research and development intensity, lengthy product development cycles, and significant regulatory oversight. Biotechnology companies often focus on developing innovative drugs, therapies, or medical technologies that address unmet medical needs. ### Market Position As a public biotechnology company, Enveric Biosciences operates in a competitive landscape that includes numerous other biotech firms at various stages of development. The public company structure allows the company to access capital markets for funding ongoing research and development efforts, which is particularly important in the capital-intensive biotechnology sector where drug development requires substantial investment over extended timeframes. The company's visibility as a public company also provides brand awareness and credibility within the scientific, investment, and healthcare communities.